Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vivotif

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Highlights • ATRA increased vaccine specific IgA in gut secretions to Vivotif but not Dukoral or Rotarix.• ATRA increased α4β7… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2017
2017
Typhoid Vaccine Live Oral Ty21a (Vivotif) is typically well tolerated, and adverse events are infrequent and mild. To the best of… Expand
2017
2017
ABSTRACT Intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy can reduce recurrence/progression of non-muscle-invasive… Expand
2016
2016
Gastrointestinal (GI) models that mimic physiological conditions in vitro are important tools for developing and optimizing… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Young children are very susceptible to typhoid fever, emphasizing the need for vaccination in under five age groups. The… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2007
2007
The attenuated Salmonella typhi strain Ty21a is the main constituent of Vivotif®, the only attenuated live oral vaccine against… Expand
2000
2000
BACKGROUND Concerns have been expressed that in travelers the efficacy of the live oral Ty21a typhoid vaccine Vivotif could be… Expand
1998
1998
  • S. Cryz
  • Journal of travel medicine
  • 1998
  • Corpus ID: 9739205
BACKGROUND Several live attenuated vaccines against bacterial enteric pathogens have recently been licensed. These include the… Expand
1983